Stock Analysis

Yip's Chemical Holdings Full Year 2023 Earnings: EPS: HK$0.15 (vs HK$0.11 loss in FY 2022)

SEHK:408
Source: Shutterstock

Yip's Chemical Holdings (HKG:408) Full Year 2023 Results

Key Financial Results

  • Revenue: HK$3.22b (down 4.2% from FY 2022).
  • Net income: HK$86.6m (up from HK$62.8m loss in FY 2022).
  • Profit margin: 2.7% (up from net loss in FY 2022). The move to profitability was driven by lower expenses.
  • EPS: HK$0.15 (up from HK$0.11 loss in FY 2022).
revenue-and-expenses-breakdown
SEHK:408 Revenue and Expenses Breakdown May 2nd 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Coatings segment contributing a total revenue of HK$1.58b (49% of total revenue). Notably, cost of sales worth HK$2.43b amounted to 76% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to HK$571.6m (75% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of HK$65.2m. Explore how 408's revenue and expenses shape its earnings.

Yip's Chemical Holdings' share price is broadly unchanged from a week ago.

Risk Analysis

You still need to take note of risks, for example - Yip's Chemical Holdings has 2 warning signs (and 1 which shouldn't be ignored) we think you should know about.

Valuation is complex, but we're helping make it simple.

Find out whether Yip's Chemical Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.